 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
1n19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Oxidoreductase
|
 |
|
Title:
|
 |
Structure of the hsod a4v mutant
|
|
Structure:
|
 |
Superoxide dismutase [cu-zn]. Chain: a, b. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Biol. unit:
|
 |
Tetramer (from
)
|
|
Resolution:
|
 |
|
1.86Å
|
R-factor:
|
0.207
|
R-free:
|
0.260
|
|
|
Authors:
|
 |
R.M.F.Cardoso,M.M.Thayer,M.Didonato,T.P.Lo,C.K.Bruns, E.D.Getzoff,J.A.Tainer
|
Key ref:
|
 |
R.M.Cardoso
et al.
(2002).
Insights into Lou Gehrig's disease from the structure and instability of the A4V mutant of human Cu,Zn superoxide dismutase.
J Mol Biol,
324,
247-256.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
16-Oct-02
|
Release date:
|
27-Nov-02
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P00441
(SODC_HUMAN) -
Superoxide dismutase [Cu-Zn]
|
|
|
|
Seq: Struc:
|
 |
 |
 |
154 a.a.
153 a.a.*
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 3 residue positions (black
crosses)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.1.15.1.1
- Superoxide dismutase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
2 superoxide + 2 H+ = O2 + H2O2
|
 |
 |
 |
 |
 |
2
×
superoxide
|
+
|
2
×
H(+)
|
=
|
O(2)
|
+
|
H(2)O(2)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Iron or manganese or (zinc and copper)
|
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
15 terms
|
 |
|
Biological process
|
aging
|
57 terms
|
 |
|
Biochemical function
|
antioxidant activity
|
10 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Mol Biol
324:247-256
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Insights into Lou Gehrig's disease from the structure and instability of the A4V mutant of human Cu,Zn superoxide dismutase.
|
|
R.M.Cardoso,
M.M.Thayer,
M.DiDonato,
T.P.Lo,
C.K.Bruns,
E.D.Getzoff,
J.A.Tainer.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Mutations in human superoxide dismutase (HSOD) have been linked to the familial
form of amyotrophic lateral sclerosis (FALS). Amyotrophic lateral sclerosis (ALS
or Lou Gehrig's disease) is one of the most common neurodegenerative disorders
in humans. In ALS patients, selective killing of motor neurons leads to
progressive paralysis and death within one to five years of onset. The most
frequent FALS mutation in HSOD, Ala4-->Val, is associated with the most rapid
disease progression. Here we identify and characterize key differences in the
stability between the A4V mutant protein and its thermostable parent (HSOD-AS),
in which free cysteine residues were mutated to eliminate interferences from
cysteine oxidation. Denaturation studies reveal that A4V unfolds at a
guanidine-HCl concentration 1M lower than HSOD-AS, revealing that A4V is
significantly less stable than HSOD-AS. Determination and analysis of the
crystallographic structures of A4V and HSOD-AS reveal structural features likely
responsible for the loss of architectural stability of A4V observed in the
denaturation experiments. The combined structural and biophysical results
presented here argue that architectural destabilization of the HSOD protein may
underlie the toxic function of the many HSOD FALS mutations.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Stereo views of A4V and HSOD-AS structures and
electron density maps. Electron density F[o] -F[c] omit maps
near the Ala4->Val mutation site in the A4V and HSOD-AS
structures were contoured at 4.0s (blue cages). (a) Electron
density maps near Ala4 (yellow) in the HSOD-AS structure. (b)
Electron density maps near Val4 (purple) in the A4V structure.
Orange residues Phe20, Leu106, and Ile113 moved upon the
Ala4->Val mutation.
|
 |
Figure 3.
Figure 3. Structural comparison of the superposed A4V and
HSOD-AS structures. (a) Overall superposition of the A chains of
the A4V and HSOD-AS molecules. The C^a atoms of the b-strand
regions of the A chains of HSOD-AS (green) and the A chain of
A4V (red) superpose well. The subunit that was not superposed in
the A4V (red) structure falls in the middle of the subunits of
each HSOD-AS dimer that were not superposed (blue). The active
site region is indicated by the copper (gold) and zinc (gray).
The mutation site, residue 4, is shown in the A4V (Val4, yellow)
and HSOD-AS (Ala4, purple). (b) Superposition of the active site
in A4V (pink) and HSOD-AS (green). The metal-ligand bonds
(lavender spheres) are from Cu(I) to His46, His48, and His120,
and from Zn(II) to His63, His71, His80 and Asp83.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2002,
324,
247-256)
copyright 2002.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.Karaer,
C.Tarhan,
M.Pekmez,
I.Hamad,
N.Arda,
and
A.T.Sarikaya
(2010).
Expression of human A4V mutant Cu,Zn superoxide dismutase in Schizosaccharomyces pombe: investigations of its toxic properties.
|
| |
Biochem Genet, 48,
113-124.
|
 |
|
|
|
|
 |
D.S.Shin,
M.Didonato,
D.P.Barondeau,
G.L.Hura,
C.Hitomi,
J.A.Berglund,
E.D.Getzoff,
S.C.Cary,
and
J.A.Tainer
(2009).
Superoxide dismutase from the eukaryotic thermophile Alvinella pompejana: structures, stability, mechanism, and insights into amyotrophic lateral sclerosis.
|
| |
J Mol Biol, 385,
1534-1555.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.J.Perry,
A.S.Hearn,
D.E.Cabelli,
H.S.Nick,
J.A.Tainer,
and
D.N.Silverman
(2009).
Contribution of human manganese superoxide dismutase tyrosine 34 to structure and catalysis.
|
| |
Biochemistry, 48,
3417-3424.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.S.Molnar,
N.M.Karabacak,
J.L.Johnson,
Q.Wang,
A.Tiwari,
L.J.Hayward,
S.J.Coales,
Y.Hamuro,
and
J.N.Agar
(2009).
A common property of amyotrophic lateral sclerosis-associated variants: destabilization of the copper/zinc superoxide dismutase electrostatic loop.
|
| |
J Biol Chem, 284,
30965-30973.
|
 |
|
|
|
|
 |
L.Banci,
I.Bertini,
M.Boca,
V.Calderone,
F.Cantini,
S.Girotto,
and
M.Vieru
(2009).
Structural and dynamic aspects related to oligomerization of apo SOD1 and its mutants.
|
| |
Proc Natl Acad Sci U S A, 106,
6980-6985.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.Dash,
R.Metz,
H.J.Huebner,
W.Porter,
and
T.D.Phillips
(2007).
Molecular characterization of two superoxide dismutases from Hydra vulgaris.
|
| |
Gene, 387,
93.
|
 |
|
|
|
|
 |
B.R.Roberts,
J.A.Tainer,
E.D.Getzoff,
D.A.Malencik,
S.R.Anderson,
V.C.Bomben,
K.R.Meyers,
P.A.Karplus,
and
J.S.Beckman
(2007).
Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS.
|
| |
J Mol Biol, 373,
877-890.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.F.Shaw,
A.Durazo,
A.M.Nersissian,
J.P.Whitelegge,
K.F.Faull,
and
J.S.Valentine
(2006).
Local unfolding in a destabilized, pathogenic variant of superoxide dismutase 1 observed with H/D exchange and mass spectrometry.
|
| |
J Biol Chem, 281,
18167-18176.
|
 |
|
|
|
|
 |
P.J.Hart
(2006).
Pathogenic superoxide dismutase structure, folding, aggregation and turnover.
|
| |
Curr Opin Chem Biol, 10,
131-138.
|
 |
|
|
|
|
 |
A.Tiwari,
Z.Xu,
and
L.J.Hayward
(2005).
Aberrantly increased hydrophobicity shared by mutants of Cu,Zn-superoxide dismutase in familial amyotrophic lateral sclerosis.
|
| |
J Biol Chem, 280,
29771-29779.
|
 |
|
|
|
|
 |
J.S.Valentine,
P.A.Doucette,
and
S.Zittin Potter
(2005).
Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis.
|
| |
Annu Rev Biochem, 74,
563-593.
|
 |
|
|
|
|
 |
N.Fujiwara,
Y.Miyamoto,
K.Ogasahara,
M.Takahashi,
T.Ikegami,
R.Takamiya,
K.Suzuki,
and
N.Taniguchi
(2005).
Different immunoreactivity against monoclonal antibodies between wild-type and mutant copper/zinc superoxide dismutase linked to amyotrophic lateral sclerosis.
|
| |
J Biol Chem, 280,
5061-5070.
|
 |
|
|
|
|
 |
S.Antonyuk,
J.S.Elam,
M.A.Hough,
R.W.Strange,
P.A.Doucette,
J.A.Rodriguez,
L.J.Hayward,
J.S.Valentine,
P.J.Hart,
and
S.S.Hasnain
(2005).
Structural consequences of the familial amyotrophic lateral sclerosis SOD1 mutant His46Arg.
|
| |
Protein Sci, 14,
1201-1213.
|
 |
|
|
|
|
 |
B.Leinweber,
E.Barofsky,
D.F.Barofsky,
V.Ermilov,
K.Nylin,
and
J.S.Beckman
(2004).
Aggregation of ALS mutant superoxide dismutase expressed in Escherichia coli.
|
| |
Free Radic Biol Med, 36,
911-918.
|
 |
|
|
|
|
 |
M.A.Hough,
J.G.Grossmann,
S.V.Antonyuk,
R.W.Strange,
P.A.Doucette,
J.A.Rodriguez,
L.J.Whitson,
P.J.Hart,
L.J.Hayward,
J.S.Valentine,
and
S.S.Hasnain
(2004).
Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants.
|
| |
Proc Natl Acad Sci U S A, 101,
5976-5981.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.S.Ray,
and
P.T.Lansbury
(2004).
A possible therapeutic target for Lou Gehrig's disease.
|
| |
Proc Natl Acad Sci U S A, 101,
5701-5702.
|
 |
|
|
|
|
 |
C.M.Higgins,
C.Jung,
and
Z.Xu
(2003).
ALS-associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes.
|
| |
BMC Neurosci, 4,
16.
|
 |
|
|
|
|
 |
J.S.Valentine,
and
P.J.Hart
(2003).
Misfolded CuZnSOD and amyotrophic lateral sclerosis.
|
| |
Proc Natl Acad Sci U S A, 100,
3617-3622.
|
 |
|
|
|
|
 |
P.B.Stathopulos,
J.A.Rumfeldt,
G.A.Scholz,
R.A.Irani,
H.E.Frey,
R.A.Hallewell,
J.R.Lepock,
and
E.M.Meiering
(2003).
Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis show enhanced formation of aggregates in vitro.
|
| |
Proc Natl Acad Sci U S A, 100,
7021-7026.
|
 |
|
|
|
|
 |
R.E.Steward,
M.W.MacArthur,
R.A.Laskowski,
and
J.M.Thornton
(2003).
Molecular basis of inherited diseases: a structural perspective.
|
| |
Trends Genet, 19,
505-513.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|